Arch Therapeutics, Inc.
ARTH · OTC
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$5,655 | -$1,469 | -$2,682 | -$2,457 |
| Dep. & Amort. | $0 | $1 | $1 | $1 |
| Deferred Tax | $0 | $0 | $1,792 | -$186 |
| Stock-Based Comp. | $10 | -$3 | $26 | $36 |
| Change in WC | $356 | $346 | $777 | $363 |
| Other Non-Cash | $4,376 | $220 | -$777 | $1,016 |
| Operating Cash Flow | -$912 | -$700 | -$863 | -$1,227 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | -$5 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | -$5 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $2,040 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $2,210 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$1,125 | $521 | $846 | $1,367 |
| Financing Cash Flow | $915 | $521 | $846 | $1,367 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $4 | -$179 | -$17 | $136 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $26 | $206 | $223 | $87 |
| End Cash | $30 | $26 | $206 | $223 |
| Free Cash Flow | -$912 | -$700 | -$863 | -$1,231 |